News, How To's & Offers

Sign up to receive occasional emails from SDIX. We strive to deliver valuable information and savings to you.

Contact Us

Do you have questions? Want to place an order?

Bookmark and Share

Successful Immunoprecipitation Following Production of an Anti-Human Ubiquitin Antibody


The development of antibodies against highly conserved proteins is a major challenge to scientists.  Due to target homology with native proteins in the host animal, successfully eliciting a robust immune
response adequate for quality reagent production is exceedingly difficult. Ubiquitin consists of 76 amino
acids and has a molecular mass of about 8500 Da. It is highly conserved among eukaryotic species:
human and yeast ubiquitin share 96% sequence homology.  Ubiquitin is implicated in many human
disease pathways. 
Success_1  
 
By utilizing proprietary plasmid design in the Genomic Antibody Technology™ platform, scientists at SDIX produced a specific anti-human ubiquitin antibody in a mouse host.  Engineered genetic adjuvants in the plasmid were able to mobilize the mouse’s immune system to react strongly to the internally expressed

recombinant protein.  This “breaking of tolerance” allows the production of specific reagents to traditionally elusive proteins. 

 Success_2